Concepedia

E. Delande

ED

Statistics

Publications

1

Citations

14

H-Index

1

Active since

2017

Affiliations

Centre d'Investigation Clinique de Nantes(Current)

E. Delande is an author at Centre d'Investigation Clinique de Nantes specializing in high-dose chemotherapy, non-hodgkin lymphoma therapy, and medical oncology.

Publications per year

2017–2017

1

Publications

1

Carboplatin instead of cisplatin in combination with dexamethasone, high-dose cytarabine with or without rituximab (DHAC+/−R) is an effective treatment with low toxicity in Hodgkin’s and non-Hodgkin’s lymphomas

Benoît Tessoulin, P. Thomaré, E. Delande et al. · Annals of Hematology · 2017 · 14 citations

Medicine, Oncology, Pharmacology +17

1–1 of 1